Annual report
Page 1
grovella THERAPEUTICS Appendix 4E Annual Report 30 June 2026 Arovella Therapeutics Limited ABN 35 090 987 250
Loading workspace
grovella THERAPEUTICS Appendix 4E Annual Report 30 June 2026 Arovella Therapeutics Limited ABN 35 090 987 250
Your watchlist and earnings event details are available after you sign in.